Crossmark

ASO Visual Abstract: Can We Forego Sentinel Lymph Node Biopsy in Women ≥50 Years of Age with Early-Stage Hormone Receptor-Positive HER2-Negative Special Histologic Subtype Breast Cancer?

Crossref DOI link: https://doi.org/10.1245/s10434-022-12726-3

Published Online: 2022-11-04

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Knape, Nicole

Park, Ji-Hye

Agala, Chris B.

Spanheimer, Philip

Morrow, Monica

Downs-Canner, Stephanie https://orcid.org/0000-0002-6870-3285
Baldwin, Xavier L.
License Information

Text and Data Mining valid from 2022-11-04

Version of Record valid from 2022-11-04
More Information

Article History

First Online: 4 November 2022

Disclosures

: Nicole Knape, Ji-Hye Park, Chris B. Agala, Philip Spanheimer, Monica Morrow, Stephanie Downs-Canner, and Xavier L. Baldwin declare no conflicts of interest.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below